Xingyun Qi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xingyun Qi has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Huiliang Zhang
Department of Medical Genetics and Molecular Biochemistry, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA
4 shared publications - Keiko U. Torii
The University of Texas at Austin
4 shared publications - Jonathan H. Dang
University of Washington
2 shared publications - Michal Maes
Institute for Systems Biology, Seattle, USA
2 shared publications - Scott M. Zeng
University of Washington SEattle, Seattle, WA, United States
2 shared publications - Aditya Birla
Center for Computational and Integrative Biology, Rutgers University , Camden, NJ 08103
1 shared publication
Latest Publications
- Open Access
Mitochondrial-Targeted SS-31 Attenuates the Doxorubicin-Induced Cardiomyoblast H9C2 Cell Senescence
Doxorubicin (DOX), an effective chemotherapeutic agent for many types of cancer, is known for significant cardiotoxic side effects, which largely limit its clinical usage. A 3 h treatment of cardiomyoblast H9C2 cells with a low concentration of DOX (100 nM) can induce senescence-associated β-galactosidase (SA β-gal) staining, a gold standard of cell senescence. In the current study, we comprehensively characterized the phenotype of the DOX-induced senescent cardiomyocytes for the first time. Establishing this in vitro model will facilitate an expanded capacity for searching for effective treatments for DOX-induced cell senescence. Using SA β-gal staining and cell growth rate as readouts, we assessed the concentration-dependent effect of DOX on H9C2 cell senescence. The cells were treated with DOX for 3 h and subsequently cultured for 3 days. We found that a 50 nM concentration of DOX induced ~50% SA β-gal staining and completely inhibited cell growth. The DOX-induced H9C2 cell senescence was further confirmed by several well-accepted senescence markers, including cell hypertrophy, increased p16 and p21 expression, increased Senescence Associated Secretory Phenotype (SASP) markers, arrested cell cycle, and increased ROS production. Interestingly, we found that 50 nM DOX increased mitochondrial respiration. Translationally, we found that mitochondrial-targeted tetrapeptide SS-31 (elamipretide, 1 µM) partially attenuated 50 nM DOX-induced SA β-gal staining from 51.4% to 35.8%. SS-31 also prevented increases in the p16, p21, and SASP markers and mitigated mitochondrial ROS production. Additionally, SS-31 reversed the 50 nM DOX-induced elevation of mitochondrial respiration. However, 1 µM SS-31 failed to prevent the cell cycle arrest induced by 50 nM DOX. Using a 3 h treatment of 50 nM DOX, we established an H9C2 cell senescence model. Treatment with SS-31 attenuates this DOX-induced cell senescence but not the cell cycle arrest. These data suggest that SS-31 is a promising drug to treat DOX-induced cardiomyocyte senescence.
Open AccessMitochondrial-Targeted SS-31 Attenuates the Doxorubicin-Induced Cardiomyoblast H9C2 Cell Senescence
Doxorubicin (DOX), an effective chemotherapeutic agent for many types of cancer, is known for significant cardiotoxic side effects, which largely limit its clinical usage. A 3 h treatment of cardiomyoblast H9C2 cells with a low concentration of DOX (100 nM) can induce senescence-associated β-galactosidase (SA β-gal) staining, a gold standard of cell senescence. In the current study, we comprehensively characterized the phenotype of the DOX-induced senescent cardiomyocytes for the first time. Establishing this in vitro model will facilitate an expanded capacity for searching for effective treatments for DOX-induced cell senescence. Using SA β-gal staining and cell growth rate as readouts, we assessed the concentration-dependent effect of DOX on H9C2 cell senescence. The cells were treated with DOX for 3 h and subsequently cultured for 3 days. We found that a 50 nM concentration of DOX induced ~50% SA β-gal staining and completely inhibited cell growth. The DOX-induced H9C2 cell senescence was further confirmed by several well-accepted senescence markers, including cell hypertrophy, increased p16 and p21 expression, increased Senescence Associated Secretory Phenotype (SASP) markers, arrested cell cycle, and increased ROS production. Interestingly, we found that 50 nM DOX increased mitochondrial respiration. Translationally, we found that mitochondrial-targeted tetrapeptide SS-31 (elamipretide, 1 µM) partially attenuated 50 nM DOX-induced SA β-gal staining from 51.4% to 35.8%. SS-31 also prevented increases in the p16, p21, and SASP markers and mitigated mitochondrial ROS production. Additionally, SS-31 reversed the 50 nM DOX-induced elevation of mitochondrial respiration. However, 1 µM SS-31 failed to prevent the cell cycle arrest induced by 50 nM DOX. Using a 3 h treatment of 50 nM DOX, we established an H9C2 cell senescence model. Treatment with SS-31 attenuates this DOX-induced cell senescence but not the cell cycle arrest. These data suggest that SS-31 is a promising drug to treat DOX-induced cardiomyocyte senescence.
- Open Access
- 15 December 2025
- Published by Scilight Press Pty Ltd in International Journal of Drug Discovery and Pharmacology
- Vol. 4 (4)
Nuclear Receptor-Targeted Therapy for Metabolic Dysfunction-Associated Steatotic Liver Disease
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease worldwide, affecting over 25% of the global population. Metabolic dysfunction-associated steatohepatitis (MASH) is an advanced stage of MASLD, characterized by hepatic steatosis accompanied by inflammation, hepatocellular injury, and fibrosis. Despite its high prevalence and clinical significance, effective treatments for MASLD and MASH remain limited, largely due to the complexity of the underlying pathophysiological mechanism, which remains not yet fully understood. Nuclear receptors (NRs) are a superfamily of transcription factors and play a key role in regulating lipid metabolism, glucose homeostasis, inflammation, and fibrosis, all of which are central to MASLD progression. Consequently, NRs have emerged as promising molecular targets for MASLD treatment, and a few new NR-targeted drugs were approved recently, including thyroid hormone receptor-β (THR-β) agonist resmetirom, the dual peroxisome proliferator-activated receptor (PPAR) - α/γ agonist saroglitazar. Moreover, several NR-targeted drugs are under clinical trials. In this mini-review, we summarize the recent progress of the mechanisms of key NRs in the pathogenesis of MASLD, and discuss the advances in nuclear receptor-targeted therapy, with emphasis on THR-β, PPARs, and the non-bile acid farnesoid X receptor (FXR).
- 15 December 2025
- Published by Scilight Press Pty Ltd in International Journal of Drug Discovery and Pharmacology
- Vol. 4 (4)
Open AccessNuclear Receptor-Targeted Therapy for Metabolic Dysfunction-Associated Steatotic Liver Disease
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease worldwide, affecting over 25% of the global population. Metabolic dysfunction-associated steatohepatitis (MASH) is an advanced stage of MASLD, characterized by hepatic steatosis accompanied by inflammation, hepatocellular injury, and fibrosis. Despite its high prevalence and clinical significance, effective treatments for MASLD and MASH remain limited, largely due to the complexity of the underlying pathophysiological mechanism, which remains not yet fully understood. Nuclear receptors (NRs) are a superfamily of transcription factors and play a key role in regulating lipid metabolism, glucose homeostasis, inflammation, and fibrosis, all of which are central to MASLD progression. Consequently, NRs have emerged as promising molecular targets for MASLD treatment, and a few new NR-targeted drugs were approved recently, including thyroid hormone receptor-β (THR-β) agonist resmetirom, the dual peroxisome proliferator-activated receptor (PPAR) - α/γ agonist saroglitazar. Moreover, several NR-targeted drugs are under clinical trials. In this mini-review, we summarize the recent progress of the mechanisms of key NRs in the pathogenesis of MASLD, and discuss the advances in nuclear receptor-targeted therapy, with emphasis on THR-β, PPARs, and the non-bile acid farnesoid X receptor (FXR).
- Open Access
- 30 September 2025
- Published by Oxford University Press (OUP) in Plant Physiology
- Vol. 199 (2)
The peptide EPFL8 represses embryonic stomatal precursor formation independently of TOO MANY MOUTHS in Arabidopsis
Plants regulate gas exchange through stomata, which are specialized valves on the aerial epidermis. Stomatal development involves tightly controlled transitions orchestrated by basic helix-loop-helix transcription factors, including SPEECHLESS (SPCH). These factors coordinate cell division and differentiation during stomatal development. Recent studies have underscored the importance of cell–cell communication in this process, mediated by secreted peptide ligands of the EPIDERMAL PATTERNING FACTOR (EPF) family and a Leucine-Rich-Repeat Receptor complex that includes ERECTA family receptor kinases and the receptor TOO MANY MOUTHS (TMM). Although mature stomata do not form during embryogenesis, stomatal cell fate is determined at these early stages. In this study, we discovered that EPFL8 is highly expressed during early embryogenesis and inhibits stomatal development by negatively regulating SPCH. Furthermore, TMM, a SPCH target, interferes with EPFL8-mediated signaling. In the absence of TMM, EPFL8 expression extends into later embryogenesis, which aligns with the reduced number of stomatal precursors observed in tmm mutants. These findings reveal that EPFL8 functions as an embryonic peptide ligand that suppresses stomatal formation via SPCH regulation, highlighting the diversification of EPF family members in fine-tuning plant epidermal patterning.
- 30 September 2025
- Published by Oxford University Press (OUP) in Plant Physiology
- Vol. 199 (2)
Open AccessThe peptide EPFL8 represses embryonic stomatal precursor formation independently of TOO MANY MOUTHS in Arabidopsis
Plants regulate gas exchange through stomata, which are specialized valves on the aerial epidermis. Stomatal development involves tightly controlled transitions orchestrated by basic helix-loop-helix transcription factors, including SPEECHLESS (SPCH). These factors coordinate cell division and differentiation during stomatal development. Recent studies have underscored the importance of cell–cell communication in this process, mediated by secreted peptide ligands of the EPIDERMAL PATTERNING FACTOR (EPF) family and a Leucine-Rich-Repeat Receptor complex that includes ERECTA family receptor kinases and the receptor TOO MANY MOUTHS (TMM). Although mature stomata do not form during embryogenesis, stomatal cell fate is determined at these early stages. In this study, we discovered that EPFL8 is highly expressed during early embryogenesis and inhibits stomatal development by negatively regulating SPCH. Furthermore, TMM, a SPCH target, interferes with EPFL8-mediated signaling. In the absence of TMM, EPFL8 expression extends into later embryogenesis, which aligns with the reduced number of stomatal precursors observed in tmm mutants. These findings reveal that EPFL8 functions as an embryonic peptide ligand that suppresses stomatal formation via SPCH regulation, highlighting the diversification of EPF family members in fine-tuning plant epidermal patterning.
- Open Access
- 19 March 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (3) , 439
Salivary-Gland-Mediated Nitrate Recirculation as a Modulator for Cardiovascular Diseases
Cardiovascular diseases (CVDs), which include multiple disorders of the heart and blood vessels, are the leading causes of death. Nitric oxide (NO) is a vasodilator that regulates vascular tension. Endogenous NO is produced via the L-arginine–nitric oxide synthase (NOS) pathway. In conditions of cardiovascular dysfunction, NOS activity is impaired, leading to NO deficiency. In turn, the reduction in NO bioactivity exacerbates the pathogenesis of CVDs. Exogenous intake of inorganic nitrate supplements endogenous production via the nitrate–nitrite–NO pathway to maintain the NO supply. Salivary glands play an essential role in the conversion of nitrate to NO, with approximately 25% of circulating nitrate being absorbed and secreted into saliva. As a result, salivary nitrate concentrations can exceed that in the blood by more than tenfold. This recycled nitrate in saliva serves as a reservoir for NO and performs NO-like functions when endogenous NO production is insufficient. In this review, we summarize the emerging benefits of dietary nitrate in CVDs, with a particular focus on salivary-gland-mediated nitrate recirculation in maintaining NO bioavailability and cardiovascular homeostasis. Salivary-gland-mediated nitrate recirculation provides a novel perspective for potential intervention of CVDs.
- 19 March 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (3) , 439
Open AccessSalivary-Gland-Mediated Nitrate Recirculation as a Modulator for Cardiovascular Diseases
Cardiovascular diseases (CVDs), which include multiple disorders of the heart and blood vessels, are the leading causes of death. Nitric oxide (NO) is a vasodilator that regulates vascular tension. Endogenous NO is produced via the L-arginine–nitric oxide synthase (NOS) pathway. In conditions of cardiovascular dysfunction, NOS activity is impaired, leading to NO deficiency. In turn, the reduction in NO bioactivity exacerbates the pathogenesis of CVDs. Exogenous intake of inorganic nitrate supplements endogenous production via the nitrate–nitrite–NO pathway to maintain the NO supply. Salivary glands play an essential role in the conversion of nitrate to NO, with approximately 25% of circulating nitrate being absorbed and secreted into saliva. As a result, salivary nitrate concentrations can exceed that in the blood by more than tenfold. This recycled nitrate in saliva serves as a reservoir for NO and performs NO-like functions when endogenous NO production is insufficient. In this review, we summarize the emerging benefits of dietary nitrate in CVDs, with a particular focus on salivary-gland-mediated nitrate recirculation in maintaining NO bioavailability and cardiovascular homeostasis. Salivary-gland-mediated nitrate recirculation provides a novel perspective for potential intervention of CVDs.
- Open Access
- 11 October 2021
- Published by Frontiers Media SA in Frontiers in Plant Science
- Vol. 12
Stomatal Lineage Control by Developmental Program and Environmental Cues
Stomata are micropores that allow plants to breathe and play a critical role in photosynthesis and nutrient uptake by regulating gas exchange and transpiration. Stomatal development, therefore, is optimized for survival and growth of the plant despite variable environmental conditions. Signaling cascades and transcriptional networks that determine the birth, proliferation, and differentiation of a stomate have been identified. These networks ensure proper stomatal patterning, density, and polarity. Environmental cues also influence stomatal development. In this review, we highlight recent findings regarding the developmental program governing cell fate and dynamics of stomatal lineage cells at the cell state- or single-cell level. We also overview the control of stomatal development by environmental cues as well as developmental plasticity associated with stomatal function and physiology. Recent advances in our understanding of stomatal development will provide a route to improving photosynthesis and water-stress resilience of crop plants in the climate change we currently face.
- 11 October 2021
- Published by Frontiers Media SA in Frontiers in Plant Science
- Vol. 12
Open AccessStomatal Lineage Control by Developmental Program and Environmental Cues
Stomata are micropores that allow plants to breathe and play a critical role in photosynthesis and nutrient uptake by regulating gas exchange and transpiration. Stomatal development, therefore, is optimized for survival and growth of the plant despite variable environmental conditions. Signaling cascades and transcriptional networks that determine the birth, proliferation, and differentiation of a stomate have been identified. These networks ensure proper stomatal patterning, density, and polarity. Environmental cues also influence stomatal development. In this review, we highlight recent findings regarding the developmental program governing cell fate and dynamics of stomatal lineage cells at the cell state- or single-cell level. We also overview the control of stomatal development by environmental cues as well as developmental plasticity associated with stomatal function and physiology. Recent advances in our understanding of stomatal development will provide a route to improving photosynthesis and water-stress resilience of crop plants in the climate change we currently face.
- Open Access
- 2 November 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-14
Armadillo-repeat kinesin1 interacts with Arabidopsis atlastin RHD3 to move ER with plus-end of microtubules
In living cells, dynamics of the endoplasmic reticulum (ER) are driven by the cytoskeleton motor machinery as well as the action of ER-shaping proteins such as atlastin GTPases including RHD3 in Arabidopsis. It is not known if the two systems interplay, and, if so, how they do. Here we report the identification of ARK1 (Armadillo-Repeat Kinesin1) via a genetic screen for enhancers of the rhd3 mutant phenotype. In addition to defects in microtubule dynamics, ER organization is also defective in mutants lacking a functional ARK1. In growing root hair cells, ARK1 comets predominantly localize on the growing-end of microtubules and partially overlap with RHD3 in the cortex of the subapical region. ARK1 co-moves with RHD3 during tip growth of root hair cells. We show that there is a functional interdependence between ARK1 and RHD3. ARK1 physically interacts with RHD3 via its armadillo domain (ARM). In leaf epidermal cells where a polygonal ER network can be resolved, ARK1, but not ARK1ΔARM, moves together with RHD3 to pull an ER tubule toward another and stays with the newly formed 3-way junction of the ER for a while. We conclude that ARK1 acts together with RHD3 to move the ER on microtubules to generate a fine ER network.
- 2 November 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-14
Open AccessArmadillo-repeat kinesin1 interacts with Arabidopsis atlastin RHD3 to move ER with plus-end of microtubules
In living cells, dynamics of the endoplasmic reticulum (ER) are driven by the cytoskeleton motor machinery as well as the action of ER-shaping proteins such as atlastin GTPases including RHD3 in Arabidopsis. It is not known if the two systems interplay, and, if so, how they do. Here we report the identification of ARK1 (Armadillo-Repeat Kinesin1) via a genetic screen for enhancers of the rhd3 mutant phenotype. In addition to defects in microtubule dynamics, ER organization is also defective in mutants lacking a functional ARK1. In growing root hair cells, ARK1 comets predominantly localize on the growing-end of microtubules and partially overlap with RHD3 in the cortex of the subapical region. ARK1 co-moves with RHD3 during tip growth of root hair cells. We show that there is a functional interdependence between ARK1 and RHD3. ARK1 physically interacts with RHD3 via its armadillo domain (ARM). In leaf epidermal cells where a polygonal ER network can be resolved, ARK1, but not ARK1ΔARM, moves together with RHD3 to pull an ER tubule toward another and stays with the newly formed 3-way junction of the ER for a while. We conclude that ARK1 acts together with RHD3 to move the ER on microtubules to generate a fine ER network.
- Open Access
- 14 August 2020
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 9
The manifold actions of signaling peptides on subcellular dynamics of a receptor specify stomatal cell fate
Receptor endocytosis is important for signal activation, transduction, and deactivation. However, how a receptor interprets conflicting signals to adjust cellular output is not clearly understood. Using genetic, cell biological, and pharmacological approaches, we report here that ERECTA-LIKE1 (ERL1), the major receptor restricting plant stomatal differentiation, undergoes dynamic subcellular behaviors in response to different EPIDERMAL PATTERNING FACTOR (EPF) peptides. Activation of ERL1 by EPF1 induces rapid ERL1 internalization via multivesicular bodies/late endosomes to vacuolar degradation, whereas ERL1 constitutively internalizes in the absence of EPF1. The co-receptor, TOO MANY MOUTHS is essential for ERL1 internalization induced by EPF1 but not by EPFL6. The peptide antagonist, Stomagen, triggers retention of ERL1 in the endoplasmic reticulum, likely coupled with reduced endocytosis. In contrast, the dominant-negative ERL1 remained dysfunctional in ligand-induced subcellular trafficking. Our study elucidates that multiple related yet unique peptides specify cell fate by deploying the differential subcellular dynamics of a single receptor.
- 14 August 2020
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 9
Open AccessThe manifold actions of signaling peptides on subcellular dynamics of a receptor specify stomatal cell fate
Receptor endocytosis is important for signal activation, transduction, and deactivation. However, how a receptor interprets conflicting signals to adjust cellular output is not clearly understood. Using genetic, cell biological, and pharmacological approaches, we report here that ERECTA-LIKE1 (ERL1), the major receptor restricting plant stomatal differentiation, undergoes dynamic subcellular behaviors in response to different EPIDERMAL PATTERNING FACTOR (EPF) peptides. Activation of ERL1 by EPF1 induces rapid ERL1 internalization via multivesicular bodies/late endosomes to vacuolar degradation, whereas ERL1 constitutively internalizes in the absence of EPF1. The co-receptor, TOO MANY MOUTHS is essential for ERL1 internalization induced by EPF1 but not by EPFL6. The peptide antagonist, Stomagen, triggers retention of ERL1 in the endoplasmic reticulum, likely coupled with reduced endocytosis. In contrast, the dominant-negative ERL1 remained dysfunctional in ligand-induced subcellular trafficking. Our study elucidates that multiple related yet unique peptides specify cell fate by deploying the differential subcellular dynamics of a single receptor.
- Open Access
The Manifold Actions of Signaling Peptides on Subcellular Dynamics of a Receptor Specify Stomatal Cell Fate
Receptor endocytosis is important for signal activation and transduction. However, how a receptor interprets conflicting signals to adjust cellular output is not clearly understood. During plant development, the family of EPIDERMAL PATTERNING FACTOR (EPF) peptides fine-tunes stomatal patterning through ERECTA-family receptor kinases. Using genetic, cell biological, and pharmacological approaches, we report here that ERECTA-LIKE1 (ERL1), the major receptor restricting stomatal differentiation, undergoes dynamic subcellular behaviors in response to different signal inputs. ERL1 is constitutively recycled, whereas its activation by EPF1 peptide induces rapid internalization to multivesicular bodies (MVB). In contrast, the dominant-negative ERL1 resides predominantly in plasma membrane. The co-receptor, TOO MANY MOUTHS (TMM), is essential for EPF1-induced ERL1 internalization but dispensable for EPFL6-induced ERL1 internalization. The peptide antagonist of EPF1, Stomagen/EPFL9, triggers retention of ERL1 in the endoplasmic reticulum. Our study elucidates that multiple related yet unique peptides specify cell fate by deploying the differential subcellular dynamics of a single receptor.
Open AccessThe Manifold Actions of Signaling Peptides on Subcellular Dynamics of a Receptor Specify Stomatal Cell Fate
Receptor endocytosis is important for signal activation and transduction. However, how a receptor interprets conflicting signals to adjust cellular output is not clearly understood. During plant development, the family of EPIDERMAL PATTERNING FACTOR (EPF) peptides fine-tunes stomatal patterning through ERECTA-family receptor kinases. Using genetic, cell biological, and pharmacological approaches, we report here that ERECTA-LIKE1 (ERL1), the major receptor restricting stomatal differentiation, undergoes dynamic subcellular behaviors in response to different signal inputs. ERL1 is constitutively recycled, whereas its activation by EPF1 peptide induces rapid internalization to multivesicular bodies (MVB). In contrast, the dominant-negative ERL1 resides predominantly in plasma membrane. The co-receptor, TOO MANY MOUTHS (TMM), is essential for EPF1-induced ERL1 internalization but dispensable for EPFL6-induced ERL1 internalization. The peptide antagonist of EPF1, Stomagen/EPFL9, triggers retention of ERL1 in the endoplasmic reticulum. Our study elucidates that multiple related yet unique peptides specify cell fate by deploying the differential subcellular dynamics of a single receptor.
- 1 September 2018
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 131 (17) , jcs222604
Meeting report – Cellular gateways: expanding the role of endocytosis in plant development
The occasion of The Company of Biologists' workshop ‘Cellular gateways: expanding the role of endocytosis in plant development’ on 22–25 April 2018, at Wiston House, an Elizabethan mansion in West Sussex, England, witnessed stimulating and lively discussions on the mechanism and functions of endocytosis in plant cells. The workshop was organized by Jenny Russinova, Daniël Van Damme (both VIB/University of Ghent, Belgium) and Takashi Ueda (National Institute for Basic Biology, Okazaki, Japan), and aimed to bridge the gap in knowledge about the endocytic machinery and its cargos in the plant field.
- 1 September 2018
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 131 (17) , jcs222604
Meeting report – Cellular gateways: expanding the role of endocytosis in plant development
The occasion of The Company of Biologists' workshop ‘Cellular gateways: expanding the role of endocytosis in plant development’ on 22–25 April 2018, at Wiston House, an Elizabethan mansion in West Sussex, England, witnessed stimulating and lively discussions on the mechanism and functions of endocytosis in plant cells. The workshop was organized by Jenny Russinova, Daniël Van Damme (both VIB/University of Ghent, Belgium) and Takashi Ueda (National Institute for Basic Biology, Okazaki, Japan), and aimed to bridge the gap in knowledge about the endocytic machinery and its cargos in the plant field.
- Open Access
MUTE Directly Orchestrates Cell State Switch and the Single Symmetric Division to Create Stomata
SUMMARY: Precise cell division control is critical for developmental patterning. For the differentiation of a functional stoma, a cellular valve for efficient gas exchange, the single symmetric division of an immediate precursor is absolutely essential. Yet, the mechanism governing the single division event remains unclear. Here we report the complete inventories of gene expression by the Arabidopsis bHLH protein MUTE, a potent inducer of stomatal differentiation. MUTE switches the gene expression program initiated by its sister bHLH, SPEECHLESS. MUTE directly induces a suite of cell-cycle genes, including CYCD5;1, and their transcriptional repressors, FAMA and FOUR LIPS . The architecture of the regulatory network initiated by MUTE represents an Incoherent Type 1 Feed-Forward Loop. Our mathematical modeling and experimental perturbations support a notion that MUTE orchestrates a transcriptional cascade leading to the tightly-restricted, robust pulse of cell-cycle gene expression, thereby ensuring the single cell division to create functional stomata. Highlights: Complete inventories of gene expression in stomatal differentiation state are elucidated MUTE switches stomatal patterning program initiated by its sister bHLH, SPEECHLESS MUTE directly induces cell-cycle genes and their direct transcriptional repressors Incoherent feed-forward loop by MUTE ensures the single division of a stomatal precursor
Open AccessMUTE Directly Orchestrates Cell State Switch and the Single Symmetric Division to Create Stomata
SUMMARY: Precise cell division control is critical for developmental patterning. For the differentiation of a functional stoma, a cellular valve for efficient gas exchange, the single symmetric division of an immediate precursor is absolutely essential. Yet, the mechanism governing the single division event remains unclear. Here we report the complete inventories of gene expression by the Arabidopsis bHLH protein MUTE, a potent inducer of stomatal differentiation. MUTE switches the gene expression program initiated by its sister bHLH, SPEECHLESS. MUTE directly induces a suite of cell-cycle genes, including CYCD5;1, and their transcriptional repressors, FAMA and FOUR LIPS . The architecture of the regulatory network initiated by MUTE represents an Incoherent Type 1 Feed-Forward Loop. Our mathematical modeling and experimental perturbations support a notion that MUTE orchestrates a transcriptional cascade leading to the tightly-restricted, robust pulse of cell-cycle gene expression, thereby ensuring the single cell division to create functional stomata. Highlights: Complete inventories of gene expression in stomatal differentiation state are elucidated MUTE switches stomatal patterning program initiated by its sister bHLH, SPEECHLESS MUTE directly induces cell-cycle genes and their direct transcriptional repressors Incoherent feed-forward loop by MUTE ensures the single division of a stomatal precursor